Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
D'Amico
Anthony V
AV
D000726:Androgen Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000532:radiotherapy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011878:Radiotherapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013739:Testosterone / Q000097:blood
D000726:Androgen Antagonists; D013739:Testosterone